Chofu Seisakusho Co., Ltd.
Chofu Seisakusho Co., Ltd. (5946.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Chofu Seisakusho Co., Ltd. (5946.T), covering cash flow, earnings, and balance sheets.
Chofu Seisakusho Co., Ltd. (5946.T) Income Statement & Financial Overview
Explore comprehensive income reports for Chofu Seisakusho Co., Ltd. 5946.T, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $10.97B | $14.40B | $11.49B | $9.62B |
Cost of Revenue | $8.61B | $10.90B | $8.96B | $7.77B |
Gross Profit | $2.36B | $3.50B | $2.54B | $1.85B |
Gross Profit Ratio | $0.22 | $0.24 | $0.22 | $0.19 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $365.00M |
SG&A Expenses | $2.11B | $2.29B | $2.18B | $1.72B |
Operating Expenses | $2.11B | $2.29B | $2.19B | $2.09B |
Total Costs & Expenses | $10.73B | $13.19B | $11.14B | $9.85B |
Interest Income | $244.00M | $0.00 | $0.00 | $240.00M |
Interest Expense | $1.00M | $0.00 | $0.00 | $2.00M |
Depreciation & Amortization | $424.00M | $316.00M | $287.75M | $357.00M |
EBITDA | $1.28B | $1.52B | $638.75M | $815.00M |
EBITDA Ratio | $0.12 | $0.11 | $0.06 | $0.08 |
Operating Income | $248.00M | $1.21B | $350.00M | -$235.00M |
Operating Income Ratio | $0.02 | $0.08 | $0.03 | -$0.02 |
Other Income/Expenses (Net) | $604.00M | $676.00M | $919.00M | $690.00M |
Income Before Tax | $852.00M | $1.88B | $1.27B | $455.00M |
Income Before Tax Ratio | $0.08 | $0.13 | $0.11 | $0.05 |
Income Tax Expense | $293.00M | $590.00M | $396.00M | $108.00M |
Net Income | $558.00M | $1.29B | $873.00M | $347.00M |
Net Income Ratio | $0.05 | $0.09 | $0.08 | $0.04 |
EPS | $16.41 | $38.00 | $25.71 | $10.22 |
Diluted EPS | $16.41 | $38.00 | $25.71 | $10.22 |
Weighted Avg Shares Outstanding | $34.004M | $34.004M | $33.96M | $33.94M |
Weighted Avg Shares Outstanding (Diluted) | $34.004M | $34.004M | $33.96M | $33.94M |
Over the past four quarters, Chofu Seisakusho Co., Ltd. demonstrated steady revenue growth, increasing from $9.62B in Q2 2024 to $10.97B in Q1 2025. Operating income reached $248.00M in Q1 2025, maintaining a consistent 2% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.28B, reflecting operational efficiency. Net income dropped to $558.00M, with EPS at $16.41. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan